Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All HCQ studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19hcq.org COVID-19 treatment researchHCQHCQ (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   
0 0.5 1 1.5 2+ Mortality 73% Improvement Relative Risk HCQ for COVID-19  Cangiano et al.  LATE TREATMENT Is late treatment with HCQ beneficial for COVID-19? Retrospective 98 patients in Italy Lower mortality with HCQ (p=0.03) c19hcq.org Cangiano et al., Aging, December 2020 Favors HCQ Favors control

Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests

Cangiano et al., Aging, doi:10.18632/aging.202307
Dec 2020  
  Post
  Facebook
Share
  Source   PDF   All   Meta
HCQ for COVID-19
1st treatment shown to reduce risk in March 2020
 
*, now known with p < 0.00000000001 from 421 studies, recognized in 42 countries.
No treatment is 100% effective. Protocols combine complementary and synergistic treatments. * >10% efficacy in meta analysis with ≥3 clinical studies.
3,800+ studies for 60+ treatments. c19hcq.org
73% lower mortality with HCQ. Analysis of 98 PCR+ nursing home residents in Italy, mean age 90, showing HCQ mortality RR 0.27, p = 0.03. Subject to confounding by contraindication. The paper provides the p value for regression but not the effect size.
Study covers vitamin D and HCQ.
risk of death, 73.4% lower, RR 0.27, p = 0.03, treatment 5 of 33 (15.2%), control 37 of 65 (56.9%), NNT 2.4.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Cangiano et al., 22 Dec 2020, retrospective, Italy, peer-reviewed, 14 authors.
This PaperHCQAll
Mortality in an Italian nursing home during COVID-19 pandemic: correlation with gender, age, ADL, vitamin D supplementation, and limitations of the diagnostic tests
Biagio Cangiano, Letizia Maria Fatti, Leila Danesi, Giacomo Gazzano, Marina Croci, Giovanni Vitale, Luisa Gilardini, Stefania Bonadonna, Iacopo Chiodini, Chiara Francesca Caparello, Antonio Conti, Luca Persani, Marco Stramba-Badiale, Marco Bonomi
Introduction: The COVID-19 pandemic caused an increased mortality in nursing homes due to its quick spread and the age-related high lethality. Results: We observed a two-month mortality of 40%, compared to 6.4% in the previous year. This increase was seen in both COVID-19 positive (43%) and negative (24%) residents, but 8 patients among those testing negative on the swab, tested positive on serological tests. Increased mortality was associated with male gender, older age, no previous vitamin D supplementation and worse "activities of daily living (ADL)" scores, such as Barthel index, Tinetti scale and S.OS.I.A. classification. Conclusion: Our data confirms a higher geriatric mortality due to COVID-19. Negative residents also had higher mortality, which we suspect is secondary to preanalytical error and a low sensitivity of the swab test in poorly compliant subjects. Male gender, older age and low scores on ADL scales (probably due to immobility) are risk factors for COVID-19 related mortality. Finally, mortality was inversely associated with vitamin D supplementation. Design: In this observational study, we described the two-month mortality among the 157 residents (age 60-100) of a nursing home after Sars-CoV-2 spreading, reporting the factors associated with the outcome. We also compared the diagnostic tests for Sars-CoV-2.
AUTHOR CONTRIBUTIONS
References
Abrams, Loomer, Gandhi, Grabowski, Characteristics of U.S. Nursing homes with COVID-19 cases, J Am Geriatr Soc, doi:10.1111/jgs.16661
Adamo, Yoshikawa, Ouslander, Coronavirus disease 2019 in geriatrics and long-term care: the ABCDs of COVID-19, J Am Geriatr Soc, doi:10.1111/jgs.16445
Annweiler, Hanotte, De L'eprevier, Sabatier, Lafaie et al., Vitamin D and survival in COVID-19 patients: a quasi-experimental study, J Steroid Biochem Mol Biol, doi:10.1016/j.jsbmb.2020.105771
Arons, Hatfield, Reddy, Kimball, James et al., Public Health-Seattle, and King County, and CDC COVID-19 Investigation Team. Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility, N Engl J Med, doi:10.1056/NEJMoa2008457
Burki, England and wales see 20 000 excess deaths in care homes, Lancet, doi:10.1016/S0140-6736(20)31199-5
Cao, COVID-19: immunopathology and its implications for therapy, Nat Rev Immunol, doi:10.1038/s41577-020-0308-3
Chen, Zhou, Dong, Qu, Gong et al., Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet, doi:10.1016/S0140-6736(20)30211-7
Clarfield, Dwolatzky, Brill, Press, Glick et al., Israel ad hoc COVID-19 committee: guidelines for care of older persons during a pandemic, J Am Geriatr Soc, doi:10.1111/jgs.16554
Davidson, Szanton, Nursing homes and COVID-19: we can and should do better, J Clin Nurs, doi:10.1111/jocn.15297
Deng, Liu, Liu, Fang, Shang et al., Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study, Chin Med J (Engl), doi:10.1097/CM9.0000000000000824
Dotti, Casale, Zacchi, Lovaglio, Fazzone, SOSIA classification of the frail elderly in nursing homes of region of lombardy
Du, Tu, Zhu, Mu, Wang et al., Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study, Am J Respir Crit Care Med, doi:10.1164/rccm.202003-0543OC
Emami, Javanmardi, Pirbonyeh, Akbari, Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and metaanalysis, Arch Acad Emerg Med
Galvis, Spinelli, Tello, Sossa, Higuera et al., Hydroxychloroquine as prophylaxis for coronavirus AGING SARS-CoV-2 infection: review of the ongoing clinical trials, Arch Bronconeumol, doi:10.1016/j.arbres.2020.05.008
Geriatrics, American geriatrics society policy brief: COVID-19 and nursing homes, J Am Geriatr Soc, doi:10.1111/jgs.16477
Guan, Ni, Hu, Liang, Ou et al., China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China, N Engl J Med, doi:10.1056/NEJMoa2002032
Guo, Li, Dong, Zhou, Zhang et al., Diabetes is a risk factor for the progression and prognosis of COVID-19, Diabetes Metab Res Rev, doi:10.1002/dmrr.3319
Hoogendijk, Smit, Van Dam, Schuster, De Breij et al., Frailty combined with loneliness or social isolation: an elevated risk for mortality in later life, J Am Geriatr Soc, doi:10.1111/jgs.16716
Hu, Sun, Dai, Deng, Li et al., Prevalence and severity of corona virus disease 2019 (COVID-19): a systematic review and metaanalysis, J Clin Virol, doi:10.1016/j.jcv.2020.104371
Huang, Wang, Li, Ren, Zhao et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, doi:10.1016/S0140-6736(20)30183-5
Kemenesi, Kornya, Tóth, Kurucz, Zeghbib et al., Nursing homes and the elderly regarding the COVID-19 pandemic: situation report from Hungary, Geroscience, doi:10.1007/s11357-020-00195-z
Lauer, Grantz, Bi, Jones, Zheng et al., The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application, Ann Intern Med, doi:10.7326/M20-0504
Levi, Thachil, Iba, Levy, Coagulation abnormalities and thrombosis in patients with COVID-19, Lancet Haematol, doi:10.1016/S2352-3026(20)30145-9
Li, Guan, Wu, Wang, Zhou et al., Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia, N Engl J Med, doi:10.1056/NEJMoa2001316
Liu, Fang, Deng, Liu, Wang et al., Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province, Chin Med J (Engl), doi:10.1097/CM9.0000000000000744
Mahoney, Barthel, Functional evaluation: the barthel index, Md State Med J
Paces, Strizova, Smrz, Cerny, COVID-19 and the immune system, Physiol Res, doi:10.33549/physiolres.934492
Pan, Mu, Yang, Sun, Wang et al., Clinical Characteristics of COVID-19 Patients With Digestive AGING Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study, Am J Gastroenterol, doi:10.14309/ajg.0000000000000620
Panagiotou, Tee, Ihsan, Athar, Marchitelli et al., Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalized with COVID-19 are associated with greater disease severity, Clin Endocrinol (Oxf), doi:10.1111/cen.14276
Richardson, Hirsch, Narasimhan, Crawford, Mcginn et al., and the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area, JAMA, doi:10.1001/jama.2020.6775
Rodriguez-Morales, Cardona-Ospina, Gutiérrez-Ocampo, Villamizar-Peña, Holguin-Rivera et al., Latin American Network of Coronavirus Disease 2019-COVID-19 Research
Roques, Klein, Papaïx, Sar, Soubeyrand, Using early data to estimate the actual infection fatality ratio from COVID-19 in France, Biology, doi:10.3390/biology9050097
Sethuraman, Jeremiah, Ryo, Interpreting diagnostic tests for SARS-CoV-2, JAMA, doi:10.1001/jama.2020.8259
Tan, Seetharaman, COVID-19 outbreak in nursing homes in Singapore, J Microbiol Immunol Infect, doi:10.1016/j.jmii.2020.04.018
Tang, Bai, Chen, Gong, Li et al., Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, J Thromb Haemost, doi:10.1111/jth.14817
Tang, Li, Wang, Sun, Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia, J Thromb Haemost, doi:10.1111/jth.14768
Thachil, Tang, Gando, Falanga, Cattaneo et al., ISTH interim guidance on recognition and management of coagulopathy in COVID-19, J Thromb Haemost, doi:10.1111/jth.14810
Tinetti, Performance-oriented assessment of mobility problems in elderly patients, J Am Geriatr Soc, doi:10.1111/j.1532-5415.1986.tb05480.x
Tse, Pun, Benzie, Experiencing SARS: perspectives of the elderly residents and health care professionals in a Hong Kong nursing home, Geriatr Nurs, doi:10.1016/s0197-4572(03)00251-9
Viecca, Radovanovic, Forleo, Santus, Enhanced platelet inhibition treatment improves hypoxemia in patients with severe covid-19 and hypercoagulability. A case control, proof of concept study, Pharmacol Res, doi:10.1016/j.phrs.2020.104950
Wang, Fang, Zhu, Chen, Ding et al., Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang hospital, Clin Microbiol Infect, doi:10.1016/j.cmi.2020.03.032
Wang, Hu, Hu, Zhu, Liu et al., Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China, JAMA, doi:10.1001/jama.2020.1585
Wu, Chen, Cai, Xia, Zhou et al., Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China, JAMA Intern Med, doi:10.1001/jamainternmed.2020.0994
Xu, Wu, Jiang, Xu, Ying et al., Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series, BMJ, doi:10.1136/bmj.m606
Zhou, Yu, Du, Fan, Liu et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, doi:10.1016/S0140-6736(20)30566-3
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit